Valiant Laboratories Ltd.

Financial

	Valiant Laboratories	Jenburkt Pharma	Albert David
Operational Metrics
Financials
5 yr Average ROE	9.35 %	18.49 %	11.47 %
5yr average Equity Multiplier	1.76	1.17	1.63
5yr Average Asset Turnover Ratio	0.81	0.88	0.62
5yr Avg Net Profit Margin	2.4 %	18.1 %	11.31 %
Price to Book	2.03	2.84	1.17
P/E	0.0	15.06	72.72
5yr Avg Cash Conversion Cycle	75.62 Days	-32.02 Days	-77.77 Days
Inventory Days	18.84 Days	24.72 Days	47.91 Days
Days Receivable	161.25 Days	48.38 Days	27.87 Days
Days Payable	82.33 Days	82.6 Days	140.35 Days
5yr Average Interest Coverage Ratio	44.93	87.2	93.73
5yr Avg ROCE	7.68 %	24.44 %	14.69 %
5yr Avg Operating Profit Margin	0.79 %	22.46 %	9.55 %
5 yr average Debt to Equity	0.48	0.02	0.02
5yr CAGR Net Profit	n/a	14.21 %	-4.92 %
5yr Average Return on Assets	4.39 %	15.8 %	7.03 %
Shareholdings
Promoter Holding	74.94 %	46.67 %	62.24 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.0	0.94 %	0.25 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

Business

	Valiant Laboratories	Jenburkt Pharma	Albert David
Product Wise Break-Up	Product Wise Break-Up Paracetamol 100.0 Pharmaceuticals 0 Dermatology 0	Product Wise Break-Up Pharmaceutical 100.0 Paracetamol 0 Dermatology 0	Product Wise Break-Up Pharmaceutical 100.0 Paracetamol 0 Dermatology 0
Location Wise Break-Up	Location Wise Break-Up India 99.52 Rest of the World 0 Others 0.48	Location Wise Break-Up Rest of the World 12.56 India 87.23 Others 0.21	Location Wise Break-Up Rest of the World 6.76 India 93.24
Asset Break-Up - Geography Wise	Asset Break-Up - Geography Wise India 100.0	-	-